FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SUVEMCITUG
异名/同义词APX 003
APX-003
BD-0801
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX 003 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX 003 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY (GAMMA1 HEAVY CHAIN HUMANIZED (1-452) (VH (HOMO SAPIENS IGHV3-21*01 (74.7%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT (9.8.14) (26-34.52-59.98-111)) (1-122) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (219) (123-220), HINGE 1-15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363)(346-450), CHS (451-452)) (123-452)), (225-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV1-6*01 (85.4%) -IGKJ4*01 (100%), CDR-IMGT (8.3.12) (27-34.52-54.91-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (158), V101 (196)(113'-219')); DIMER (231-231'':234-234'')-BISDISULFIDE; PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA)
SEVACIZUMAB
SEVACIZUMAB [WHO-DD]
SUVEMCITUG
SUVEMCITUG [INN]
CAS登记号1610010-57-5
物质唯一标识(Unique Ingredient Identifier)T7Y5VC4ERJ
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System